---
title: "Shanghai Fudan-Zhangjiang Bio-Pharmaceutical subscribes to structured deposit product under Bank of China"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/281521127.md"
description: "Shanghai Fudan-Zhangjiang Bio-Pharmaceutical subscribes to structured deposit product under Bank of China"
datetime: "2026-04-02T12:08:32.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/281521127.md)
  - [en](https://longbridge.com/en/news/281521127.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/281521127.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/281521127.md) | [English](https://longbridge.com/en/news/281521127.md)


# Shanghai Fudan-Zhangjiang Bio-Pharmaceutical subscribes to structured deposit product under Bank of China



### 相關股票

- [FUDANZHANGJIANG (01349.HK)](https://longbridge.com/zh-HK/quote/01349.HK.md)
- [BANK OF CHINA (03988.HK)](https://longbridge.com/zh-HK/quote/03988.HK.md)
- [Bank Of China (601988.CN)](https://longbridge.com/zh-HK/quote/601988.CN.md)
- [ChinaAMC SSE STAR Biology and Medicine ETF (588130.CN)](https://longbridge.com/zh-HK/quote/588130.CN.md)
- [ChinaAMC SSE Health Care ETF Initiating Fund (510660.CN)](https://longbridge.com/zh-HK/quote/510660.CN.md)
- [Bank of China (BACHY.US)](https://longbridge.com/zh-HK/quote/BACHY.US.md)
- [E Fund CSI 300 Health Care ETF (512010.CN)](https://longbridge.com/zh-HK/quote/512010.CN.md)
- [China Merchants CSI Biotechnology Theme ETF (159849.CN)](https://longbridge.com/zh-HK/quote/159849.CN.md)
- [ChinaAMC CSI Biotechnology Theme ETF (516500.CN)](https://longbridge.com/zh-HK/quote/516500.CN.md)
- [E Fund CSI Biotechnology Theme ETF (159837.CN)](https://longbridge.com/zh-HK/quote/159837.CN.md)
- [Guotai CSI Bio-medicine ETF (512290.CN)](https://longbridge.com/zh-HK/quote/512290.CN.md)
- [Fudan-Zhangjiang (688505.CN)](https://longbridge.com/zh-HK/quote/688505.CN.md)

## 相關資訊與研究

- [ImmuneOnco Doses First Patient in Phase III Trial of CD47/CD20 Bispecific for Lymphoma](https://longbridge.com/zh-HK/news/281068292.md)
- [10:00 ETSanyou Milestone | Recognized as a "Shanghai Municipal Enterprise Technology Center," Further Validating for Innovation Excellence](https://longbridge.com/zh-HK/news/281035304.md)
- [Bank of China Publishes 2025 Pillar 3 Risk and Capital Disclosure](https://longbridge.com/zh-HK/news/280992471.md)
- [Bank of China (OTCMKTS:BACHY) Issues Earnings Results](https://longbridge.com/zh-HK/news/281191632.md)
- [Bank of China posts 2.18% rise in 2025 profit](https://longbridge.com/zh-HK/news/280985241.md)